CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 231 enrolled
Drug / intervention
Ivermectin 3Mg Tabdrug
Likely dose
Ivermectin 3Mg Tabfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03517462
NCT03517462N/ACompleted
CompareCT.gov

Microfilarial Clearance From the Eye and Ocular Changes Associated With Ivermectin Treatment in Individuals With Onchocerciasis

Washington University School of Medicine·interventional·Posted May 7, 2018·Updated Dec 31, 2020

In Brief

A clinical study evaluating Ivermectin 3Mg Tab for Onchocerciasis. Completed, enrolled 231 participants across 1 site.

Detailed Summary

The DOLF Ocular Changes after Ivermectin study will investigate the kinetics of O. volvulus microfilaria (Mf) in the eye following treatment with ivermectin. The primary objective is to determine the proportion of participants with complete Mf clearance from the eye at 3 and 6 months following treatment with ivermectin (IVM).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOnchocerciasis
CountriesGhana
CollaboratorsCase Western Reserve University, University of Health and Allied Sciences

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedMay 7, 2018
Enrollment StartAug 6, 2018
Primary CompletionAug 23, 2019
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 8.2 years ago

Interventions

Ivermectin 3Mg Tabdrug

ivermectin tablet